相关实验视频
Updated: Jun 28, 2025

08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
12.7K
根据老年痴呆症严重程度对口腔功能评估的可行性 患有阿尔茨海默病的老年人
Maki Shirobe1, Ayako Edahiro1, Keiko Motokawa1
1Research Team for Promoting Independence and Mental Health, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo 173-0015, Japan.
Nutrients
|April 13, 2024
概括
对患有严重阿尔茨海默病 (AD) 的老年人来说,口腔功能评估具有挑战性. 对于那些患有晚期痴呆症的人来说,需要新的,更简单的吞评估.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 语音和听力科学 语言和听力科学
背景情况:
- 口腔功能评估对于痴呆症老年人的饮食支持至关重要.
- 挑战包括在评估期间的认知和合作困难.
- 在这个人群中,口腔功能评估的可行性尚未得到研究.
研究的目的:
- 确定阿尔茨海默病 (AD) 的老年人口腔功能评估的可行性.
- 评估AD严重程度 (FAST阶段) 和评估可行性之间的关系.
主要方法:
- 对428名患有AD的老年人进行横截面研究.
- 评估了口服二子运动 (ODK) 的可行性,重复的唾液吞试验 (RSST) 和修改的水吞试验 (MWST).
- 使用多层逻辑回归模型来分析基于阿尔茨海默病功能评估分期 (FAST) 阶段的数据.
主要成果:
- 严重的AD (FAST阶段7) 与不可行性有显著的关联.
- 在严重的AD中,对ODK (26.7),RSST (5.9) 和MWST (8.7) 的不可行性进行调整的赔率比率很高.
- 随着AD严重程度的增加,可行性明显下降.
结论:
- 在患有严重AD的老年人中,口腔功能评估很困难.
- 需要更简单,更实用的吞评估,以便在这个人群中进行常规观察.
相关概念视频
Assessment of the Mouth
189
A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
189
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183

